Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis
- PMID: 18666225
- PMCID: PMC3592568
- DOI: 10.1002/hep.22399
Beyond insulin resistance: Innate immunity in nonalcoholic steatohepatitis
Abstract
Obesity is an inflammatory disorder characterized by heightened activity of the innate immune system. Innate immune activation is central to the development of obesity-related insulin resistance; it also plays an important role in obesity-related tissue damage, such as that seen in atherosclerosis. Recent research has implicated the innate immune system in the pathophysiology of obesity-related liver disease. This review summarizes how innate immune processes, occurring both within and outside the liver, cause not only insulin resistance but also end-organ damage in the form of nonalcoholic fatty liver disease.
Conflict of interest statement
Potential conflict of interest: Nothing to report.
Figures
References
-
- Hotamisligil GS. Inflammation and metabolic disorders. Nature. 2006;444:860–867. - PubMed
-
- Farrell GC, Larter CZ. Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology. 2006;43:S99–S112. - PubMed
-
- Gao Z, Zhang X, Zuberi A, Hwang D, Quon MJ, Lefevre M, et al. Inhibition of insulin sensitivity by free fatty acids requires activation of multiple serine kinases in 3T3–L1 adipocytes. Mol Endocrinol. 2004;18:2024–2034. - PubMed
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources